Home LiteratureArticle Details
PMID: 18347038 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine.

Infection and immunity ·Vol. 76 ·No. 6 ·2008-06-00 ·Pages 2531-40

Jones SA, Jorgensen M, Chowdhury FZ, Rodgers R, Hartline J, Leatham MP, Struve C, Krogfelt KA, Cohen PS, Conway T

Abstract

Mutant screens and transcriptome studies led us to consider whether the metabolism of glucose polymers, i.e., maltose, maltodextrin, and glycogen, is important for Escherichia coli colonization of the intestine. By using the streptomycin-treated mouse model, we found that catabolism of the disaccharide maltose provides a competitive advantage in vivo to pathogenic E. coli O157:H7 and commensal E. coli K-12, whereas degradation of exogenous forms of the more complex glucose polymer, maltodextrin, does not. The endogenous glucose polymer, glycogen, appears to play an important role in colonization, since mutants that are unable to synthesize or degrade glycogen have significant colonization defects. In support of the hypothesis that E. coli relies on internal carbon stores to maintain colonization during periods of famine, we found that by providing a constant supply of a readily metabolized sugar, i.e., gluconate, in the animal's drinking water, the competitive disadvantage of E. coli glycogen metabolism mutants is rescued. The results suggest that glycogen storage may be widespread in enteric bacteria because it is necessary for maintaining rapid growth in the intestine, where there is intense competition for resources and occasional famine. An important implication of this study is that the sugars used by E. coli are present in limited quantities in the intestine, making endogenous carbon stores valuable. Thus, there may be merit to combating enteric infections by using probiotics or prebiotics to manipulate the intestinal microbiota in such a way as to limit the availability of sugars preferred by E. coli O157:H7 and perhaps other pathogens.

MeSH Terms
Animals Drug Resistance, Bacterial Escherichia coli Infections/microbiology Escherichia coli O157/drug effects,genetics,metabolism Gluconates/metabolism Glycogen/metabolism Intestines/microbiology Male Maltose/metabolism Mice Mutation Phenotype Polysaccharides/metabolism Streptomycin/pharmacology Time Factors
Chemicals
Gluconates Polysaccharides Maltose maltodextrin Glycogen gluconic acid Streptomycin
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Jones Shari A
Advanced Center for Genome Technology, University of Oklahoma, Norman, Oklahoma 73019, USA.
Jorgensen Mathias
Chowdhury Fatema Z
Rodgers Rosalie
Hartline James
Leatham Mary P
Struve Carsten
Krogfelt Karen A
Cohen Paul S
Conway Tyrrell
References (40)
40 references, click to expand
  1. Occurrence of more than one important source of ADPglucose linked to glycogen biosynthesis in Escherichia coli and Salmonella.
    FEBS Lett. 2007 Sep 18;581(23):4423-9 PMID: 17719035
  2. STUDIES ON THE ENDOGENOUS METABOLISM OF ESCHERICHIA COLI.
    Biochem J. 1965 May;95:332-43 PMID: 14340081
  3. Application of a novel multi-screening signature-tagged mutagenesis assay for identification of Klebsiella pneumoniae genes essential in colonization and infection.
    Microbiology (Reading). 2003 Jan;149(Pt 1):167-76 PMID: 12576590
  4. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures.
    Appl Environ Microbiol. 2005 Oct;71(10):6150-8 PMID: 16204533
  5. Carbohydrate bioavailability.
    Br J Nutr. 2005 Jul;94(1):1-11 PMID: 16115326
  6. Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation.
    Microbiol Mol Biol Rev. 1998 Mar;62(1):204-29 PMID: 9529892
  7. Escherichia coli mutants impaired in maltodextrin transport.
    J Bacteriol. 1979 Oct;140(1):1-13 PMID: 387714
  8. Structure of GlgS from Escherichia coli suggests a role in protein-protein interactions.
    BMC Biol. 2004 May 25;2:10 PMID: 15161493
  9. L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.
    Infect Immun. 2007 Nov;75(11):5465-75 PMID: 17709419
  10. EFFECTS OF ENVIRONMENT ON THE COMPOSITION OF BACTERIAL CELLS.
    Annu Rev Microbiol. 1963;17:61-86 PMID: 14145314
  11. Carbon nutrition of Escherichia coli in the mouse intestine.
    Proc Natl Acad Sci U S A. 2004 May 11;101(19):7427-32 PMID: 15123798
  12. Glycogen phosphorylase, the product of the glgP Gene, catalyzes glycogen breakdown by removing glucose units from the nonreducing ends in Escherichia coli.
    J Bacteriol. 2006 Jul;188(14):5266-72 PMID: 16816199
  13. Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.
    Infect Immun. 2005 Dec;73(12):8039-49 PMID: 16299298
  14. Glycogen production by different Salmonella enterica serotypes: contribution of functional glgC to virulence, intestinal colonization and environmental survival.
    Microbiology (Reading). 2005 Dec;151(Pt 12):3969-3977 PMID: 16339941
  15. Bacterial "glycogen" and survival.
    Nature. 1968 Nov 9;220(5167):606-7 PMID: 4879742
  16. The adaptive responses of Escherichia coli to a feast and famine existence.
    Adv Microb Physiol. 1971;6:147-217 PMID: 4950180
  17. Bacterial glycogen synthesis and its regulation.
    Annu Rev Microbiol. 1984;38:419-58 PMID: 6093684
  18. The maltodextrin system of Escherichia coli: glycogen-derived endogenous induction and osmoregulation.
    J Bacteriol. 2005 Dec;187(24):8332-9 PMID: 16321937
  19. Hungry bacteria--definition and properties of a nutritional state.
    Environ Microbiol. 2001 Oct;3(10):605-11 PMID: 11722540
  20. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine.
    Infect Immun. 2008 Mar;76(3):1143-52 PMID: 18180286
  21. Fermentation in the human large intestine and the available substrates.
    Am J Clin Nutr. 1987 May;45(5 Suppl):1243-55 PMID: 3034048
  22. Biosynthesis of bacterial glycogen. Primary structure of Escherichia coli ADP-glucose:alpha-1,4-glucan, 4-glucosyltransferase as deduced from the nucleotide sequence of the glgA gene.
    J Biol Chem. 1986 Dec 5;261(34):16256-9 PMID: 3097003
  23. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.
    Infect Immun. 2003 Apr;71(4):2142-52 PMID: 12654836
  24. Role of the Escherichia coli glgX gene in glycogen metabolism.
    J Bacteriol. 2005 Feb;187(4):1465-73 PMID: 15687211
  25. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.
    Appl Environ Microbiol. 2006 Dec;72(12):7835-41 PMID: 17056678
  26. Identification and molecular analysis of glgS, a novel growth-phase-regulated and rpoS-dependent gene involved in glycogen synthesis in Escherichia coli.
    Mol Microbiol. 1992 Jul;6(14):1877-86 PMID: 1324388
  27. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.
    Infect Immun. 2004 Mar;72(3):1666-76 PMID: 14977974
  28. The malX malY operon of Escherichia coli encodes a novel enzyme II of the phosphotransferase system recognizing glucose and maltose and an enzyme abolishing the endogenous induction of the maltose system.
    J Bacteriol. 1991 Aug;173(15):4862-76 PMID: 1856179
  29. On the glycogen in Escherichia coli B; electron microscopy of ultrathin sections of cells.
    J Ultrastruct Res. 1959 Oct;3:70-3 PMID: 13808718
  30. Vancomycin-resistant Enterococci may obtain nutritional support by scavenging carbohydrate fragments generated during mucin degradation by the anaerobic microbiota of the colon.
    Microb Drug Resist. 2006 Spring;12(1):63-7 PMID: 16584311
  31. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 PMID: 10829079
  32. The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis.
    FEMS Microbiol Lett. 2000 Oct 1;191(1):31-6 PMID: 11004396
  33. Alpha-amylase of Escherichia coli, mapping and cloning of the structural gene, malS, and identification of its product as a periplasmic protein.
    J Biol Chem. 1986 Feb 25;261(6):2946-53 PMID: 3005273
  34. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.
    J Nutr. 1995 Jun;125(6):1401-12 PMID: 7782892
  35. Simultaneous identification of bacterial virulence genes by negative selection.
    Science. 1995 Jul 21;269(5222):400-3 PMID: 7618105
  36. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
    Infect Immun. 1990 Aug;58(8):2438-45 PMID: 2196227
  37. Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching.
    Eur J Biochem. 1976 May 17;65(1):13-9 PMID: 776623
  38. Degradation of polysaccharides by intestinal bacterial enzymes.
    Am J Clin Nutr. 1978 Oct;31(10 Suppl):S128-S130 PMID: 707363
  39. Culture medium for enterobacteria.
    J Bacteriol. 1974 Sep;119(3):736-47 PMID: 4604283
  40. Substrate preference of Bifidobacterium adolescentis MB 239: compared growth on single and mixed carbohydrates.
    Appl Microbiol Biotechnol. 2006 Dec;73(3):654-62 PMID: 16865345
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
1098-5522
Published
2008-06-00
Epub
2008-00-17
Pages
2531-40
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC2423072
Subset
IM
Grants
NIAID NIH HHS · R01 AI048945 · United States
NIAID NIH HHS · R56 AI048945 · United States
NIAID NIH HHS · AI48945 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com